GPC2 and neoplasm: To evaluate the activity of GPC2-CAR T cells in vivo, we stereotactically implanted D283 or MAF1433 into the cerebellum of NOD SCID gamma (NSG) mice (4–6 weeks old) (Figure 3A), which establishes orthotopic tumor (Figure 3B; Figures S3A and S3B).